Refine by
Structure Based Drug Discovery Suppliers For Served Medical Health Care
7 companies found
based inMartinsried, GERMANY
Proteros is a Munich-based provider of structure-based early stage drug discovery services with a cutting-edge discovery engine tailored to unlock even the most technically challenging drug targets. Proteros supports its clients to reach the right ...
based inVilligen, SWITZERLAND
leadXpro specializes in structure-based drug discovery for membrane proteins. leadXpro is a team of experts in membrane protein science. We have an integrated platform for membrane protein biochemistry, biophysics and structural biology, including ...
based inChicago, ILLINOIS (USA)
Our company began as Nymirum. As protein drug discovery continued to exhaust low-hanging fruits, we founded Nymirum in 2009 to tackle a new and challenging frontier filled with untapped therapeutic potential: targeting RNA with small molecules. We ...
based inBaltimore, MARYLAND (USA)
SilcsBio provides software and services for unlocking the full potential of computer driven drug design. Our algorithms for mapping proteins will provide you with a level of detail you have never before experienced. From our highly accurate free ...
based inChuo-ku, JAPAN
Sysmex has a global network of operations throughout the world. This section introduces our company profile and provides the locations of our offices and subsidiaries. Sysmex supports human health. We are an integrated company, developing and ...
based inPortland, OREGON (USA)
HTI accelerates drug discovery for Biotech and Pharma companies by providing structure determination services using cryogenic-electron microscopy (cryo-EM) and machine learning based image processing software. As a member of the Oregon Bioscience ...
based inLondon, UNITED KINGDOM
At Benevolent we build technology in the service of science - to augment human intelligence and inspire the discovery of new medicines for the thousands of diseases that have no treatment. Building the right team is an art not a science. We strive ...